Starting from our lead compound, VL-0395, an anthranilic acid based CCK1 receptor antagonist and following the well established “step by step” lead investigation strategy, we describe the final step of the anthranilic acid N-terminal optimization.
N-TERMINAL ANTHRANOYL-PHENYLALANINE DERIVATIVES AS CCK1 RECEPTOR ANTAGONISTS: THE FINAL APPROACH
VARNAVAS, ANTONIOS;LASSIANI, LUCIA;
2005-01-01
Abstract
Starting from our lead compound, VL-0395, an anthranilic acid based CCK1 receptor antagonist and following the well established “step by step” lead investigation strategy, we describe the final step of the anthranilic acid N-terminal optimization.File in questo prodotto:
Non ci sono file associati a questo prodotto.
Pubblicazioni consigliate
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
